Clinical Trials Browser

Tumor Necrosis Factor-alpha × Dermatologic × 1 year × Clear all

NCT05222932 2025-08-07

AVENTIL

Phase 1 Active not recruiting

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Melanoma